TrianecT
Latest round
- Seed
Last raised
- Jul 2025
Total raised
- $1.6M
Investors
- 1
About TrianecT
TrianecT BV, founded in 2022 and headquartered in Utrecht, Netherlands, focuses on developing solutions for stroke diagnosis.TrianecT BV specializes in innovative stroke diagnosis solutions, primarily through its flagship product, StrokePointer™. This advanced technology allows for the real-time acquisition and automatic analysis of electrical brain activity (EEG) within the ambulance setting, facilitating the rapid diagnosis of stroke. By enabling emergency medical service (EMS) personnel to triage patients effectively, StrokePointer™ aims to direct patients to the appropriate hospital for timely endovascular treatment, critically reducing the time to care.TrianecT operates a business model based on direct partnerships with healthcare providers and EMS organizations. Revenue is generated through the sale and potential subscription-based access to their StrokePointer™ technology, which may include ongoing support and updates. The transaction structure typically involves agreements with hospitals and EMS agencies, where they procure the technology for integration into their emergency response protocols. This model ensures that clients remain at the forefront of stroke management innovation while fostering long-term relationships. The company plans to expand its market reach, targeting major urban centers in Europe and North America for this new technology.
Who invested in TrianecT
1 investor across 1 round
See all investors in TrianecT
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 8, 2025
Amount
$1.6M
Investors
Questions about TrianecT
Who invested in TrianecT?
TrianecT has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TrianecT raised?
TrianecT has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TrianecT last raise money?
TrianecT's most recent round on record is a Seed, in Jul 2025.
What does TrianecT do?
TrianecT BV, founded in 2022 and headquartered in Utrecht, Netherlands, focuses on developing solutions for stroke diagnosis.
Where is TrianecT headquartered?
TrianecT is headquartered in Utrecht, Netherlands.
Which VCs invest in companies like TrianecT?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at TrianecT's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like TrianecT? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.